论文部分内容阅读
目的分析莫西沙星在治疗肺结核合并肺炎的临床疗效。方法收集我院2014年2月至2015年4月诊治的肺结核患者46例作为研究对象,采用回顾性的方式分析患者的临床资料。研究结果显示,本组患者中有25例患者确诊是肺结核并采用莫西沙星治疗,有12例患者存在较典型的结核中毒症状,大部分患者为痰菌阴性,仅有少部分患者为结核菌素试验强阳性。通过莫西沙星治疗的患者在吸收及症状改变方面均取得明显的效果。结论莫西沙星在治疗肺结核合并肺炎中具有良好的临床应用效果,值得在临床应用上推广。
Objective To analyze the clinical efficacy of moxifloxacin in the treatment of pulmonary tuberculosis complicated with pneumonia. Methods Forty-six patients with tuberculosis diagnosed and treated in our hospital from February 2014 to April 2015 were selected as the research object, and the clinical data of the patients were analyzed retrospectively. The results showed that 25 patients in this group were diagnosed as pulmonary tuberculosis and treated with moxifloxacin. Twelve patients had typical symptoms of tuberculosis. Most patients were sputum negative and only a minority of patients were tuberculosis Strong positive test. Patients treated with moxifloxacin achieved significant results in both absorption and symptomatic changes. Conclusion Moxifloxacin in the treatment of pulmonary tuberculosis complicated with pneumonia has a good clinical application, it is worth in the clinical application of promotion.